The opportunistic fungal pathogen Candida albicans poses a serious medical threat to human health. This unicellular microbe is part of the normal microbiota on the skin and mucosal surfaces of oral cavity, digestive tract and urogenital system in the patients showing no clinical symptoms. However, in patients with immunosuppression owing to HIV infection, cancer or tissue transplantation, C. albicans can become invasive and cause local and/or disseminated diseases (candidiasis), with high morbidity and mortality rates (∼40–60%).1 Clinical usefulness of the current limited arsenal of antifungal agents has been hampered by severe side effects, poor pharmacokinetic properties and emergence of multidrug resistance.2
Successful colonization and proliferation in host tissues contribute greatly to pathogenicity. One striking virulence trait of C. albicans is its capability to grow and switch between budded yeast and filamentous forms (hyphae). The phenotypic plasticity is indispensable for survival as the pathogenic fungus may experience spatial and temporal variations in different host niches. For example, the human digestive tract can vary from extreme acidity (pH<2) to alkalinity (pH>8). Importantly, external pH determines yeast-to-hypha transition,3 and a transient cytoplasmic pH burst is evident during morphological changes in C. albicans,4 suggesting a close physiological–environmental linkage between pH regulation and pathogenesis.
Membranes are vital for all living cells; not only they serve as selective barriers to the environment, but also define intracellular compartments for diverse and interconnected metabolic processes that include nutrient uptake, ion transport and protein degradation. In particular, pH homeostasis in C. albicans is tightly controlled by plasma membrane and vacuolar H+-ATPases.5 The membrane-bound ATPases generate an electrochemical proton gradient that maintains cytosolic and vacuolar pH states at the expense of ATP hydrolysis. The functional significance of ATPase activity in C. albicans morphogenesis has been illustrated, as inhibition of the enzyme activity arrested hyphal growth and null mutants were unable to form hyphae and were avirulent.4, 6 Moreover, a high degree of similarity (⩾50%) among fungal ATPases are evident, but they share lesser similarity (⩽30%) compared with their mammalian counterparts.7 It is thus conceivable that C. albicans membrane-bound ATPases may represent attractive molecular targets in the management of candidiasis through perturbation of intracellular pH balance and indirect modulation of filamentation.
We have previously demonstrated that purpurin, an anthraquinone pigment commonly found in madder root, possessed potent in vitro anti-Candidal activity, inhibited yeast-to-hypha transition and biofilm development in C. albicans.8, 9 By virtue of the linkage between morphogenesis and pH regulation, the present study was designed to investigate the effect of purpurin on the ATPase-mediated proton efflux activity in C. albicans by measuring acidification of external medium. C. albicans SC5314 was obtained from Prof. NAR Gow (University of Aberdeen) and routinely cultured in YPD agar at 30 °C. Purpurin was purchased from TimTec Inc. (Newark, DE, USA) with a purity of ⩾99%. Stock solution (5 mg ml−1) was prepared in distilled dimethyl sulphoxide (DMSO) and kept at −20 °C until use. The final concentration of DMSO was 1% in all assays. An overnight culture of C. albicans SC5314 was washed twice and resuspended in sterile cold distilled water (to deplete carbon source) at 1 × 107 cells ml−1. The cell suspension (2.7 ml) was incubated with different concentrations (0.1–0.5 μg ml−1) of purpurin at 30 °C for 20 min, followed by addition of 20% glucose (0.3 ml) to induce medium acidification. External pH was monitored by a pH meter at 10-min interval for a period of 1 h. Assaying the glucose-induced acidification of external medium is a well-known and convenient method to represent membrane ATPase activity in fungi.5, 10 Furthermore, to evaluate possible physiological disturbance on purpurin treatment, we measured the growth rates of C. albicans in the presence of 3 μg ml−1 of purpurin. Fungal cells were grown at 37 °C with agitation (250 r.p.m.) in YPD broth. Aliquots were withdrawn at 1-h intervals and fungal growth was measured turbidometrically at 600 nm. The assays were performed in triplicate in three different occasions. All data were expressed as mean values with the corresponding standard error of mean (s.e.m.).
A summary of the effect of different concentrations of purpurin on the change of external pH in C. albicans SC5314 is shown in Figure 1. The effect was significant and concentration-dependent. Comparing with the minimum inhibitory concentration (MIC=5.12 μg ml−1) of purpurin against C. albicans,8 lower levels of purpurin were able to inhibit glucose-dependent ATPase-mediated proton efflux activity and therefore perturbed pH homeostasis that led to a lesser degree of reduction in external pH. Any physiological disturbance of cellular metabolism could be eliminated as the growth of C. albicans was not affected even at a higher purpurin concentration of 3 μg ml−1 (data not shown). The effective inhibitory effect of sub-MIC levels of purpurin on C. albicans ATPases may have clinical relevance, as lower concentrations would reduce the likelihood of the development of drug resistance, especially in combinatorial chemotherapy. To conclude, the present study indicates that sub-MIC levels of purpurin were able to interfere with pH homeostasis in C. albicans and warrants further investigations.
Wenzel, R. P. & Gennings, C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis. 41, S389–S393 (2005).
Morschhäuser, J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet. Biol. 47, 94–106 (2010).
Davis, D. A. How human pathogenic fungi sense and adapt to pH: the link to virulence. Curr. Opin. Microbiol. 12, 365–370 (2009).
Kaur, S. & Mishra, P. Differential increase in cytoplasmic pH at bud and germ tube formation in Candida albicans: studies of a nongerminative variant. Can. J. Microbiol. 40, 720–723 (1994).
Shreaz, S. et al. Influences of cinnamic aldehydes on H+ extrusion activity and ultrastructure of Candida. J. Med. Microbiol. 62, 232–240 (2013).
Shapiro, R. S. & Cowen, L. E. Uncovering cellular circuitry controlling temperature-dependent fungal morphogenesis. Virulence 3, 400–404 (2012).
Perlin, D. S., Seto-Young, D. & Monk, B.C. The plasma membrane H+-ATPase of fungi: a candidate drug target? Ann. N. Y. Acad. Sci. 834, 609–617 (1997).
Kang, K., Fong, W. P. & Tsang, P. W. K. Novel antifungal activity of purpurin against Candida species in vitro. Med. Mycol. 48, 904–911 (2010).
Tsang, P. W. K., Bandara, H. M. H. N. & Fong, W. P. Purpurin suppresses Candida albicans biofilm formation and hyphal development. PLoS One 7, e50866 (2012).
Chan, G., Hardej, D., Santoro, M., Lau-Cam, C. & Billack, B. Evaluation of the antimicrobial activity of ebselen: role of the yeast plasma membrane H+-ATPase. J. Biochem. Mol. Toxicol. 21, 252–264 (2007).
This work was supported by the Research Fund for the Control of Infectious Diseases, the Food and Health Bureau of the Government of the HKSAR (RFCID 11100992); Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (HMRF 12111292).
About this article
Cite this article
Tsang, P., Wong, A., Jung, H. et al. Sub-MIC levels of purpurin inhibit membrane ATPase-mediated proton efflux activity in the human fungal pathogen Candida albicans. J Antibiot 67, 349–350 (2014). https://doi.org/10.1038/ja.2013.140
Anti-adipogenic and anti-obesity activities of purpurin in 3T3-L1 preadipocyte cells and in mice fed a high-fat diet
BMC Complementary and Alternative Medicine (2019)
Application of Time-Dependent Density Functional and Natural Bond Orbital Theories to the UV–vis Absorption Spectra of Some Phenolic Compounds
The Journal of Physical Chemistry A (2015)